Lacutamab
Lacutamab Uses, Dosage, Side Effects, Food Interaction and all others data.
Lacutamab is under investigation in clinical trial NCT02593045 (Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL)).
| Trade Name | Lacutamab |
| Generic | Lacutamab |
| Lacutamab Other Names | Lacutamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Lacutamab
